By: PRWeb
February 05, 2013 at 07:05 AM EST
Entelos Expands Executive Team
PRWeb

Entelos Holding Corp. ("Entelos" or the "Company"), a premier provider of physiological system modeling and services that help pharmaceutical and consumer product companies predict better paths to success in their development process, today announced that Dr. Mike Davies and Dr. Dominic John have joined the senior management team of the Company as Global Vice President of Sales and Vice President of Marketing, effective immediately.

"It is an indication of the opportunity ahead that we have been able to attract such seasoned and experienced executives who will, in turn, help us execute on the opportunity." said Shawn O'Connor, President and Chief Executive Officer of Entelos. "With more and more companies looking to project efficient outcomes, study less and outsource more, Entelos is ideally placed to address the market need with leading modeling technology, physiological models and experienced scientific services. Mike and Dominic both bring to Entelos over 35 years of experience leading successful scientific companies in our market space. Their contributions will be invaluable to our future investment and growth to deliver market leading strategic partnerships and predictive therapeutic solutions."

Dr. Davies has had more than 20 years of experience providing a robust background in scientific research and a track record of strong commercial leadership. Prior to joining Entelos, Dr. Davies was Vice President Global Sales of the Health Sciences GBU at Oracle Corporation after holding senior positions in Sales and Global Strategic Partnerships over 10 years at Phase Forward, Inc. and prior at Parke-Davis, a division of Warner Lambert. Dr. Davies scientific background is based in physiology and pharmacology having completed 3 years post-doctoral work at the University of Rochester.

Dr. John has had more than 15 years in research and scientific software product management and marketing having held senior positions in MDL Information Systems, Symyx Technologies and Accelrys Inc. Prior to joining Entelos, Dr. John was Director of Product Marketing at Accelrys, a $160M scientific software company. Dr. John has a scientific background that includes modeling, biochemistry and toxicology.

Entelos is a physiological modeling and simulation software and services company delivering predictive technologies reducing risk, time, and cost of product development for pharmaceutical, biotechnology, nutrition and consumer products companies. The Company's PhysioLab(R) systems biology models generate virtual drug and patient populations providing qualitative and quantitative insight and understanding to develop safer and more effective drugs and consumer products. Entelos' understanding of population variability has significant application to the emerging field of personalized medicine and market segmentation. The Company is headquartered in San Mateo, California. For more information, please visit http://www.entelos.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10386823.htm

PRWeb.com
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here